搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Yersinia pestis bv. Antiqua Sec-independent protein translocase protein TatB (tatB), partial CSB-YP627664YAG
CSB-EP627664YAG
CSB-BP627664YAG
CSB-MP627664YAG
CSB-EP627664YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua sn-glycerol-3-phosphate-binding periplasmic protein ugpB (ugpB) CSB-YP627665YAG
CSB-EP627665YAG
CSB-BP627665YAG
CSB-MP627665YAG
CSB-EP627665YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua 4-alpha-L-fucosyltransferase (wecF) CSB-YP627666YAG
CSB-EP627666YAG
CSB-BP627666YAG
CSB-MP627666YAG
CSB-EP627666YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua tRNA (uracil (54)-C (5))-methyltransferase (trmA) CSB-YP627667YAG
CSB-EP627667YAG
CSB-BP627667YAG
CSB-MP627667YAG
CSB-EP627667YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Phosphoenolpyruvate carboxylase (ppc), partial CSB-YP627668YAG
CSB-EP627668YAG
CSB-BP627668YAG
CSB-MP627668YAG
CSB-EP627668YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua ATPase ravA (ravA), partial CSB-YP627669YAG
CSB-EP627669YAG
CSB-BP627669YAG
CSB-MP627669YAG
CSB-EP627669YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Flagellar hook-basal body complex protein FliE (fliE) CSB-YP627670HAAH
CSB-EP627670HAAH
CSB-BP627670HAAH
CSB-MP627670HAAH
CSB-EP627670HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Thymidylate kinase (tmk) CSB-YP627671HAAH
CSB-EP627671HAAH
CSB-BP627671HAAH
CSB-MP627671HAAH
CSB-EP627671HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Peptidyl-tRNA hydrolase (pth) CSB-YP627672HAAH
CSB-EP627672HAAH
CSB-BP627672HAAH
CSB-MP627672HAAH
CSB-EP627672HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP627673HAAH
CSB-EP627673HAAH
CSB-BP627673HAAH
CSB-MP627673HAAH
CSB-EP627673HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Quinolinate synthase A (nadA) CSB-YP627674HAAH
CSB-EP627674HAAH
CSB-BP627674HAAH
CSB-MP627674HAAH
CSB-EP627674HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 50S ribosomal protein L23 (rplW) CSB-YP627675HAAH
CSB-EP627675HAAH
CSB-BP627675HAAH
CSB-MP627675HAAH
CSB-EP627675HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 50S ribosomal protein L5 (rplE) CSB-YP627676HAAH
CSB-EP627676HAAH
CSB-BP627676HAAH
CSB-MP627676HAAH
CSB-EP627676HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 30S ribosomal protein S13 (rpsM) CSB-YP627677HAAH
CSB-EP627677HAAH
CSB-BP627677HAAH
CSB-MP627677HAAH
CSB-EP627677HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Anthranilate phosphoribosyltransferase (trpD) CSB-YP627678HAAH
CSB-EP627678HAAH
CSB-BP627678HAAH
CSB-MP627678HAAH
CSB-EP627678HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori NADH-quinone oxidoreductase subunit B (nuoB) CSB-YP627679HAAH
CSB-EP627679HAAH
CSB-BP627679HAAH
CSB-MP627679HAAH
CSB-EP627679HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Protein CrcB homolog (crcB), partial CSB-YP627680HAAH1
CSB-EP627680HAAH1
CSB-BP627680HAAH1
CSB-MP627680HAAH1
CSB-EP627680HAAH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori 50S ribosomal protein L10 (rplJ) CSB-YP627681HAAH
CSB-EP627681HAAH
CSB-BP627681HAAH
CSB-MP627681HAAH
CSB-EP627681HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Histidine--tRNA ligase (hisS) CSB-YP627682HAAH
CSB-EP627682HAAH
CSB-BP627682HAAH
CSB-MP627682HAAH
CSB-EP627682HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter pylori Flagellar assembly factor FliW 1 (fliW1) CSB-YP627683HAAH
CSB-EP627683HAAH
CSB-BP627683HAAH
CSB-MP627683HAAH
CSB-EP627683HAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>